Tag: Gray Matter
-
Changes in Structural Network Properties and Gray Matter Volume in Patients with End-Stage Kidney Disease Without Cognitive Impairment
•
Chronic kidney diseases pose an increasing health challenge worldwide, with estimates suggesting that the number of patients with chronic kidney diseases may reach 700 million, accompanied by a significant rise in mortality rates associated with them. As public health concerns escalate due to this increase, interest continues to grow in…
-
The Role of Glutamatergic System Dysregulation in Cognitive Decline in Patients with Unilateral Temporal Lobe Epilepsy.
•
Memory and concentration problems are considered part of the major challenges faced by patients with epilepsy, specifically in cases related to the clinical picture of unilateral temporal lobe epilepsy. This article refers to a new study addressing the relationship between glymphatic dysfunction and cognitive decline in patients with unilateral temporal…
-
Title: The Relationship Between Levels of Glial-Derived Neurotrophic Factor (GDNF) and White Matter Damage in Patients with Mild Cognitive Impairment Associated with Parkinson’s Disease
•
Introduction: Mild cognitive impairment (MCI) is considered one of the common non-motor symptoms of Parkinson’s disease (PD), known as PD-MCI. Despite the prevalence of this condition, there remains a lack of comprehensive information regarding the role of glial cell line-derived neurotrophic factor (GDNF) and the impact of white matter damage…
-
Levels of Glial Fibrillary Acidic Protein as a Biomarker for Early Diagnosis of Mild Cognitive Impairment Among the Elderly in the Community
•
The issue of Mild Cognitive Impairment (MCI) is one of the significant health challenges faced by the elderly, representing a transitional stage between normal aging and Alzheimer’s disease. The importance of studying this condition lies in its potential progression to Alzheimer’s disease in up to 20% of those affected. In…